Citations (31)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Giancarlo Logroscino, Bruno P. Imbimbo, Madia Lozupone, Rodolfo Sardone, Rosa Capozzo, Petronilla Battista, Chiara Zecca, Vittorio Dibello, Gianluigi Giannelli, Antonello Bellomo, Antonio Greco, Antonio Daniele, Davide Seripa & Francesco Panza. (2019) Promising therapies for the treatment of frontotemporal dementia clinical phenotypes: from symptomatic to disease-modifying drugs. Expert Opinion on Pharmacotherapy 20:9, pages 1091-1107.
Read now
Read now
Articles from other publishers (30)
Priyadarshi Prajjwal, Singam Shashank, Saud Muthanna Shakir Al-ezzi, Bhavya Sharma, Obed Aubourg, Akshita Kaushish, Mohammed Dheyaa Marsool Marsool, Abhijit Nagre & Shahnaz Asharaf. (2023) Frontotemporal dementia: Addressing the scattered harbingers of genetics and its relationship with glucose metabolism, bipolar disorder, and amyotrophic lateral sclerosis. Disease-a-Month 69:5, pages 101545.
Crossref
Crossref
Nahuel Magrath GuimetLina M. Zapata-RestrepoBruce L. Miller. (2022) Advances in Treatment of Frontotemporal Dementia. The Journal of Neuropsychiatry and Clinical Neurosciences 34:4, pages 316-327.
Crossref
Crossref
Mario F. Mendez. (2022) Managing the Behavioral and Psychological Symptoms of Dementia. Current Treatment Options in Neurology 24:5, pages 183-201.
Crossref
Crossref
Tommaso B. Jannini, Giorgio D. Lorenzo, Emanuela Bianciardi, Cinzia Niolu, Massimiliano Toscano, Giacomo Ciocca, Emmanuele A. Jannini & Alberto Siracusano. (2022) Off-label Uses of Selective Serotonin Reuptake Inhibitors (SSRIs). Current Neuropharmacology 20:4, pages 693-712.
Crossref
Crossref
Nadine Huber, Sonja Korhonen, Dorit Hoffmann, Stina Leskelä, Hannah Rostalski, Anne M. Remes, Paavo Honkakoski, Eino Solje & Annakaisa Haapasalo. (2021) Deficient neurotransmitter systems and synaptic function in frontotemporal lobar degeneration—Insights into disease mechanisms and current therapeutic approaches. Molecular Psychiatry 27:3, pages 1300-1309.
Crossref
Crossref
Alizée Arnoux & Luc Dupuis. 2021. 5-HT2B Receptors. 5-HT2B Receptors
367
386
.
Francesco Panza, Madia Lozupone, Davide Seripa, Antonio Daniele, Mark Watling, Gianluigi Giannelli & Bruno P. Imbimbo. (2020) Development of disease-modifying drugs for frontotemporal dementia spectrum disorders. Nature Reviews Neurology 16:4, pages 213-228.
Crossref
Crossref
Barbara Poletti, Laura Carelli, Federica Solca, Rita Pezzati, Andrea Faini, Nicola Ticozzi, Hiroshi Mitsumoto & Vincenzo Silani. (2019) Sexuality and intimacy in ALS: systematic literature review and future perspectives. Journal of Neurology, Neurosurgery & Psychiatry 90:6, pages 712-719.
Crossref
Crossref
Ángel Romero-Martínez, Sonia Murciano-Martí & Luis Moya-Albiol. (2019) Is Sertraline a Good Pharmacological Strategy to Control Anger? Results of a Systematic Review. Behavioral Sciences 9:5, pages 57.
Crossref
Crossref
Alberto Benussi, Antonella Alberici, Emanuele Buratti, Roberta Ghidoni, Fabrizio Gardoni, Monica Di Luca, Alessandro Padovani & Barbara Borroni. (2019) Toward a Glutamate Hypothesis of Frontotemporal Dementia. Frontiers in Neuroscience 13.
Crossref
Crossref
Alexander G Murley & James B Rowe. (2018) Neurotransmitter deficits from frontotemporal lobar degeneration. Brain 141:5, pages 1263-1285.
Crossref
Crossref
Michael G. Erkkinen, Mee-Ohk Kim & Michael D. Geschwind. (2018) Clinical Neurology and Epidemiology of the Major Neurodegenerative Diseases. Cold Spring Harbor Perspectives in Biology 10:4, pages a033118.
Crossref
Crossref
Juan Joseph Young, Mallika Lavakumar, Deena Tampi, Silpa Balachandran & Rajesh R. Tampi. (2017) Frontotemporal dementia: latest evidence and clinical implications. Therapeutic Advances in Psychopharmacology 8:1, pages 33-48.
Crossref
Crossref
Rosanne M. Radziewicz & Cheryl Bradas. 2018. Psychiatric Disorders Late in Life. Psychiatric Disorders Late in Life
329
344
.
Mona Shahbazi, Shara Holzberg, Saeyoan Thirunavukkarasu & Gioia Ciani. (2017) Perceptions of sexuality in individuals with Amyotrophic Lateral Sclerosis (ALS) and their treating clinicians. NeuroRehabilitation 41:2, pages 331-342.
Crossref
Crossref
Eline Wauters, Kristel Sleegers, Marc Cruts & Christine Van Broeckhoven. 2017. Disease-Modifying Targets in Neurodegenerative Disorders. Disease-Modifying Targets in Neurodegenerative Disorders
199
249
.
Luigi Lombardo & Roberta Rossi. (2016) Demenza e comportamento sessuale. RIVISTA DI SESSUOLOGIA CLINICA:1, pages 33-50.
Crossref
Crossref
Richard M. Tsai & Adam L. Boxer. 2016. Hodges' Frontotemporal Dementia. Hodges' Frontotemporal Dementia
243
261
.
. 2016. Hodges' Frontotemporal Dementia. Hodges' Frontotemporal Dementia
211
271
.
Gila Bronner, Judith Aharon-Peretz & Sharon Hassin-Baer. 2015. Neurology of Sexual and Bladder Disorders. Neurology of Sexual and Bladder Disorders
297
323
.
Richard M. Tsai & Adam L. Boxer. (2014) Treatment of Frontotemporal Dementia. Current Treatment Options in Neurology 16:11.
Crossref
Crossref
Maria Nardell & Rajesh R. Tampi. (2013) Pharmacological Treatments for Frontotemporal Dementias. American Journal of Alzheimer's Disease & Other Dementiasr 29:2, pages 123-132.
Crossref
Crossref
Mario F. Mendez & Jill S. Shapira. (2013) Hypersexual Behavior in Frontotemporal Dementia: A Comparison with Early-Onset Alzheimer’s Disease. Archives of Sexual Behavior 42:3, pages 501-509.
Crossref
Crossref
Ozel-Kizil ETSakarya ALArica BHaran S. (2013) A Case of Frontotemporal Dementia with Amyotrophic Lateral Sclerosis Presenting with Pathological Gambling. Journal of Clinical Neurology 9:2, pages 133.
Crossref
Crossref
Nathan Herrmann, Sandra E. Black, Tiffany Chow, Jaclyn Cappell, David F. Tang-Wai & Krista L. Lanctôt. (2012) Serotonergic Function and Treatment of Behavioral and Psychological Symptoms of Frontotemporal Dementia. The American Journal of Geriatric Psychiatry 20:9, pages 789-797.
Crossref
Crossref
Gregory A Jicha & Peter T Nelson. (2011) Management of frontotemporal dementia: targeting symptom management in such a heterogeneous disease requires a wide range of therapeutic options. Neurodegenerative Disease Management 1:2, pages 141-156.
Crossref
Crossref
Maria da Glória Portugal, Valeska Marinho & Jerson Laks. (2011) Pharmacological treatment of frontotemporal lobar degeneration: systematic review. Revista Brasileira de Psiquiatria 33:1, pages 81-90.
Crossref
Crossref
Robert Perneczky, Corina Pohl, Susanne Bornschein, Hans Förstl, Alexander Kurz & Janine Diehl-Schmid. (2009) Accelerated clinical decline in well-educated patients with frontotemporal lobar degenerations. European Archives of Psychiatry and Clinical Neuroscience 259:6, pages 362-367.
Crossref
Crossref
Keith A Vossel & Bruce L Miller. (2008) New approaches to the treatment of frontotemporal lobar degeneration. Current Opinion in Neurology 21:6, pages 708-716.
Crossref
Crossref
Adam L. Boxer & Bradley F. Boeve. (2007) Frontotemporal Dementia Treatment: Current Symptomatic Therapies and Implications of Recent Genetic, Biochemical, and Neuroimaging Studies. Alzheimer Disease & Associated Disorders 21:4, pages S79-S87.
Crossref
Crossref